AU610141B2 - Pharmaceutical compositions acting on the heart and cardiovascular system and process for preparing same - Google Patents

Pharmaceutical compositions acting on the heart and cardiovascular system and process for preparing same Download PDF

Info

Publication number
AU610141B2
AU610141B2 AU13261/88A AU1326188A AU610141B2 AU 610141 B2 AU610141 B2 AU 610141B2 AU 13261/88 A AU13261/88 A AU 13261/88A AU 1326188 A AU1326188 A AU 1326188A AU 610141 B2 AU610141 B2 AU 610141B2
Authority
AU
Australia
Prior art keywords
mass
fatty acids
selenium
alga
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU13261/88A
Other languages
English (en)
Other versions
AU1326188A (en
Inventor
Gyorgy Baktay
Gyorgy Blasko
Laszlo Bogdany
Maria Boross
Miklos Crosz
Miklos Fabian
Peter Literati-Nagy
Lajos Gyorgy Nagy
Gabor Nemeth
Erzsebet Pako
Janos Palinkas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAOLA KOZMETIKAI ES HAZTARTASVEGYIPARI VALLALAT
Original Assignee
CAOLA KOZMETIKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAOLA KOZMETIKAI filed Critical CAOLA KOZMETIKAI
Publication of AU1326188A publication Critical patent/AU1326188A/en
Application granted granted Critical
Publication of AU610141B2 publication Critical patent/AU610141B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU13261/88A 1987-03-18 1988-03-18 Pharmaceutical compositions acting on the heart and cardiovascular system and process for preparing same Ceased AU610141B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU1173/87 1987-03-18
HU871173A HU204199B (en) 1987-03-18 1987-03-18 Process for producing pharmaceutical compositions containing unsaturated fatty acids and selenium as active components

Publications (2)

Publication Number Publication Date
AU1326188A AU1326188A (en) 1988-09-22
AU610141B2 true AU610141B2 (en) 1991-05-16

Family

ID=10953170

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13261/88A Ceased AU610141B2 (en) 1987-03-18 1988-03-18 Pharmaceutical compositions acting on the heart and cardiovascular system and process for preparing same

Country Status (23)

Country Link
CN (1) CN88101370A (da)
AT (1) AT395818B (da)
AU (1) AU610141B2 (da)
BE (1) BE1002428A3 (da)
CH (1) CH675075A5 (da)
DD (1) DD280904A5 (da)
DE (1) DE3809225A1 (da)
DK (1) DK148788A (da)
ES (1) ES2009569A6 (da)
FI (1) FI881307A (da)
FR (1) FR2612399B1 (da)
GB (1) GB2203042B (da)
GR (1) GR1000447B (da)
HU (1) HU204199B (da)
IL (1) IL85776A (da)
IT (1) IT1216142B (da)
LU (1) LU87169A1 (da)
NL (1) NL8800693A (da)
NO (1) NO881214L (da)
PT (1) PT87017B (da)
SE (1) SE8800988L (da)
YU (1) YU55388A (da)
ZA (1) ZA881957B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210122B (en) * 1988-03-23 1995-02-28 Biorex Kutato Fejlesztoe Kft Process for production of composition against thromboembolytic conditions of circulating system and heart
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy
GB2363331B (en) * 2000-06-17 2003-02-05 Raymond Clifford Noble Supplement to enhance fertility
FR2816211B1 (fr) * 2000-11-08 2005-04-01 Brif Nouvelles compositions dietetiques et ou/cosmetiques pour ameliorer la secheresse des muqueuses
US20040076695A1 (en) 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
WO2004071519A1 (fr) * 2003-01-14 2004-08-26 Bruneau Francois Micro-organismes photosynthetiques enrichis en molecules biologiquement actives, leurs procedes de preparation, et leurs utilisations
CN107998227A (zh) * 2016-10-28 2018-05-08 新时代健康产业（集团）有限公司 一种保护心脏的保健品及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels

Also Published As

Publication number Publication date
FR2612399B1 (fr) 1991-03-29
YU55388A (en) 1989-10-31
HUT52388A (en) 1990-07-28
ZA881957B (en) 1989-01-25
DK148788A (da) 1988-09-19
DE3809225A1 (de) 1988-11-03
GR1000447B (el) 1992-07-30
DD280904A5 (de) 1990-07-25
DK148788D0 (da) 1988-03-18
FI881307A0 (fi) 1988-03-18
SE8800988D0 (sv) 1988-03-18
PT87017B (pt) 1992-06-30
NL8800693A (nl) 1988-10-17
IL85776A0 (en) 1988-09-30
FI881307A (fi) 1988-09-19
CH675075A5 (da) 1990-08-31
JPS6427A (en) 1989-01-05
AT395818B (de) 1993-03-25
NO881214L (no) 1988-09-19
HU204199B (en) 1991-12-30
GB2203042A (en) 1988-10-12
IT8819838A0 (it) 1988-03-18
LU87169A1 (fr) 1989-10-26
ES2009569A6 (es) 1989-10-01
NO881214D0 (no) 1988-03-18
FR2612399A1 (fr) 1988-09-23
AU1326188A (en) 1988-09-22
SE8800988L (sv) 1988-09-19
PT87017A (pt) 1988-04-01
GR880100170A (en) 1989-01-31
CN88101370A (zh) 1988-11-09
ATA73788A (de) 1992-08-15
BE1002428A3 (fr) 1991-02-05
IT1216142B (it) 1990-02-22
IL85776A (en) 1992-09-06
GB8806530D0 (en) 1988-04-20
GB2203042B (en) 1990-10-03

Similar Documents

Publication Publication Date Title
RU2152216C1 (ru) Композиция, содержащая диетические добавки (варианты)
US4058594A (en) Immuno-suppressive agents
ES2576578T3 (es) Composición de ácidos grasos n-3 que presentan una concentración elevada de EPA y/o DHA y que contiene ácidos grasos n-6
US7858128B2 (en) Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
US3993775A (en) Immuno-suppressive agents
GB2216421A (en) Pharmaceutical compositions acting on the heart and cardiovascular system
AU610141B2 (en) Pharmaceutical compositions acting on the heart and cardiovascular system and process for preparing same
US5041429A (en) Cell activators, circulatory ameliorators and edible compositions
KR100828069B1 (ko) 푸코잔틴 또는 이를 함유하는 해조류 추출물을 포함하는,지방간의 예방 또는 치료용 조성물
WO2009062662A1 (en) Pharmaceutical and nutraceutical compositions based on menaquinols
JPH012551A (ja) 食餌性組成物およびその製造方法
FR2612373A1 (fr) Compositions dietetiques et procede pour leur preparation
KR100828068B1 (ko) 푸코잔틴 또는 이를 함유하는 해조류 추출물을 포함하는,고지혈증의 예방 또는 치료용 조성물
US4419345A (en) Sleep-inducing pharmaceutical composition and method
EP0349143A2 (en) Use of phytic acid or its salts for the prevention or treatment of hepatic diseases
JP3441411B2 (ja) コレステロール低減化ペプチド
JPH0476971B2 (da)
AU685153B2 (en) Reduced absorption of fatty acids
JPS59175425A (ja) 脳卒中予防剤
JPH0358926A (ja) 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤、痴呆治療剤、または脳機能改善効果を有する機能性食品
JPH107553A (ja) 生体内ラジカル消去剤及び抗潰瘍剤
JP2002080357A (ja) 高血圧症予防・改善・治療剤
JP2009153529A (ja) 食品組成物
Ganesan et al. Polyphloretin phosphate temporarily potentiates prostaglandin E2 on the rat fundus, probably by inhibiting PG15-hydroxydehydrogenase
JPH0127A (ja) 心臓および心臓血管系に作用する薬剤並びにその製造方法